The first experience of using beta-hydroxybutyrate analysis of capillary blood in the diagnosis of non-diabetic hypoglycemia in adults

Background: The diagnostic threshold of β-hydroxybutyrate (BHB) at the moment of hypoglycemia in insulinoma was developed for venous blood many years ago, when there were no alternative ways to measure ketones. Number of works, mainly on patients with diabetes mellitus, found differences in the meas...

Full description

Bibliographic Details
Main Authors: M. Yu. Yukina, E. A. Troshina, N. F. Nuralieva, N. G. Mokrysheva
Format: Article
Language:English
Published: Endocrinology Research Centre 2022-09-01
Series:Ожирение и метаболизм
Subjects:
Online Access:https://www.omet-endojournals.ru/jour/article/view/12822
_version_ 1797204521618767872
author M. Yu. Yukina
E. A. Troshina
N. F. Nuralieva
N. G. Mokrysheva
author_facet M. Yu. Yukina
E. A. Troshina
N. F. Nuralieva
N. G. Mokrysheva
author_sort M. Yu. Yukina
collection DOAJ
description Background: The diagnostic threshold of β-hydroxybutyrate (BHB) at the moment of hypoglycemia in insulinoma was developed for venous blood many years ago, when there were no alternative ways to measure ketones. Number of works, mainly on patients with diabetes mellitus, found differences in the measurement of this indicator in venous and capillary blood, but the results were contradictory. Moreover, this study was not previously used in the diagnosis of non-diabetic hypoglycemia (NDH) in adults on the territory of the Russian Federation.Aim: To estimate the effectiveness of the method for determining BHB in capillary blood and its place in the diagnosis of NDH.Materials and methods: We conducted an experimental, cross-sectional, comparative study and included patients with suspected NDH who underwent a standard fast test. The BHB level in capillary blood was determined every 6 hours during the fast test and at its completion.Results: Based on the results of the fast test, the participants (n=154) were divided into groups: with hyperinsulinemic variant of NDH and IFRoma (n=98; group 1), with hypoinsulinemic variant of NDH /absence of NDH (n=56; group 2). When comparing the level of BHB at the moment of fasting completion, significant differences were obtained between groups 1 and 2 (p<0.001). According to the ROC analysis, the determination of BHB for differentiation the hyper- and hypoinsulinemic variants of hypoglycemia is characterized by excellent quality of model (AUC=99,1% [98,0%; 100,0%]). The BHB determination in capillary blood has the maximum diagnostic accuracy at a cut-off point of ≤ 1.4 mmol/L (Se 98.0%, Sp 96.4%, PPV 98.0%, NPV 96.4%, Ac 97.4%). Exceeding the diagnostic threshold of BHB was first recorded after 24h of fasting; at the same point, a significant difference was determined when comparing BHB indicators between two consecutive measurements (between 18h and 24h).Conclusion: The BHB determination in capillary blood is a highly sensitive and highly specific additional method for the differential diagnosis of NDH variants. The diagnostic threshold for BHB of capillary blood, which allows differentiating hyper- and hypoketonemic variants of NDH, is ≤1.4 mmol / L. It is advisable to initiate control of BHB in the blood no earlier than 18 hours after the start of the fast test.
first_indexed 2024-03-08T09:12:06Z
format Article
id doaj.art-3cf31834b3604f4391cc26668028d578
institution Directory Open Access Journal
issn 2071-8713
2306-5524
language English
last_indexed 2024-04-24T08:36:33Z
publishDate 2022-09-01
publisher Endocrinology Research Centre
record_format Article
series Ожирение и метаболизм
spelling doaj.art-3cf31834b3604f4391cc26668028d5782024-04-16T16:16:14ZengEndocrinology Research CentreОжирение и метаболизм2071-87132306-55242022-09-0119213414110.14341/omet1282210928The first experience of using beta-hydroxybutyrate analysis of capillary blood in the diagnosis of non-diabetic hypoglycemia in adultsM. Yu. Yukina0E. A. Troshina1N. F. Nuralieva2N. G. Mokrysheva3Endocrinology Researh CentreEndocrinology Researh CentreEndocrinology Researh CentreEndocrinology Researh CentreBackground: The diagnostic threshold of β-hydroxybutyrate (BHB) at the moment of hypoglycemia in insulinoma was developed for venous blood many years ago, when there were no alternative ways to measure ketones. Number of works, mainly on patients with diabetes mellitus, found differences in the measurement of this indicator in venous and capillary blood, but the results were contradictory. Moreover, this study was not previously used in the diagnosis of non-diabetic hypoglycemia (NDH) in adults on the territory of the Russian Federation.Aim: To estimate the effectiveness of the method for determining BHB in capillary blood and its place in the diagnosis of NDH.Materials and methods: We conducted an experimental, cross-sectional, comparative study and included patients with suspected NDH who underwent a standard fast test. The BHB level in capillary blood was determined every 6 hours during the fast test and at its completion.Results: Based on the results of the fast test, the participants (n=154) were divided into groups: with hyperinsulinemic variant of NDH and IFRoma (n=98; group 1), with hypoinsulinemic variant of NDH /absence of NDH (n=56; group 2). When comparing the level of BHB at the moment of fasting completion, significant differences were obtained between groups 1 and 2 (p<0.001). According to the ROC analysis, the determination of BHB for differentiation the hyper- and hypoinsulinemic variants of hypoglycemia is characterized by excellent quality of model (AUC=99,1% [98,0%; 100,0%]). The BHB determination in capillary blood has the maximum diagnostic accuracy at a cut-off point of ≤ 1.4 mmol/L (Se 98.0%, Sp 96.4%, PPV 98.0%, NPV 96.4%, Ac 97.4%). Exceeding the diagnostic threshold of BHB was first recorded after 24h of fasting; at the same point, a significant difference was determined when comparing BHB indicators between two consecutive measurements (between 18h and 24h).Conclusion: The BHB determination in capillary blood is a highly sensitive and highly specific additional method for the differential diagnosis of NDH variants. The diagnostic threshold for BHB of capillary blood, which allows differentiating hyper- and hypoketonemic variants of NDH, is ≤1.4 mmol / L. It is advisable to initiate control of BHB in the blood no earlier than 18 hours after the start of the fast test.https://www.omet-endojournals.ru/jour/article/view/12822non-diabetic hypoglycemiaβ-hydroxybutyratehypoglycemic syndromeketones
spellingShingle M. Yu. Yukina
E. A. Troshina
N. F. Nuralieva
N. G. Mokrysheva
The first experience of using beta-hydroxybutyrate analysis of capillary blood in the diagnosis of non-diabetic hypoglycemia in adults
Ожирение и метаболизм
non-diabetic hypoglycemia
β-hydroxybutyrate
hypoglycemic syndrome
ketones
title The first experience of using beta-hydroxybutyrate analysis of capillary blood in the diagnosis of non-diabetic hypoglycemia in adults
title_full The first experience of using beta-hydroxybutyrate analysis of capillary blood in the diagnosis of non-diabetic hypoglycemia in adults
title_fullStr The first experience of using beta-hydroxybutyrate analysis of capillary blood in the diagnosis of non-diabetic hypoglycemia in adults
title_full_unstemmed The first experience of using beta-hydroxybutyrate analysis of capillary blood in the diagnosis of non-diabetic hypoglycemia in adults
title_short The first experience of using beta-hydroxybutyrate analysis of capillary blood in the diagnosis of non-diabetic hypoglycemia in adults
title_sort first experience of using beta hydroxybutyrate analysis of capillary blood in the diagnosis of non diabetic hypoglycemia in adults
topic non-diabetic hypoglycemia
β-hydroxybutyrate
hypoglycemic syndrome
ketones
url https://www.omet-endojournals.ru/jour/article/view/12822
work_keys_str_mv AT myuyukina thefirstexperienceofusingbetahydroxybutyrateanalysisofcapillarybloodinthediagnosisofnondiabetichypoglycemiainadults
AT eatroshina thefirstexperienceofusingbetahydroxybutyrateanalysisofcapillarybloodinthediagnosisofnondiabetichypoglycemiainadults
AT nfnuralieva thefirstexperienceofusingbetahydroxybutyrateanalysisofcapillarybloodinthediagnosisofnondiabetichypoglycemiainadults
AT ngmokrysheva thefirstexperienceofusingbetahydroxybutyrateanalysisofcapillarybloodinthediagnosisofnondiabetichypoglycemiainadults
AT myuyukina firstexperienceofusingbetahydroxybutyrateanalysisofcapillarybloodinthediagnosisofnondiabetichypoglycemiainadults
AT eatroshina firstexperienceofusingbetahydroxybutyrateanalysisofcapillarybloodinthediagnosisofnondiabetichypoglycemiainadults
AT nfnuralieva firstexperienceofusingbetahydroxybutyrateanalysisofcapillarybloodinthediagnosisofnondiabetichypoglycemiainadults
AT ngmokrysheva firstexperienceofusingbetahydroxybutyrateanalysisofcapillarybloodinthediagnosisofnondiabetichypoglycemiainadults